Mendelian randomization suggests no causal association between C-reactive protein and carotid intima-media thickness in the Young Finns study [3]

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 27, Issue 4, 2007, Pages 978-979

  Kivimäki, Mika ^a   Lawlor, Debbie A ^b   Eklund, Carita ^c   Smith, George Davey ^b   Hurme, Mikko ^d   Lehtimäki, Terho ^d   Viikari, Jorma S A ^e   Raitakari, Olli T ^e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ARTERY INTIMA; ARTERY MEDIA; BODY MASS; CAROTID ARTERY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; ISCHEMIC HEART DISEASE; LETTER; METABOLIC SYNDROME X; PRIORITY JOURNAL; REGRESSION ANALYSIS; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; C-REACTIVE PROTEIN; CAROTID ARTERIES; CHILD; CHILD, PRESCHOOL; CORONARY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; TUNICA INTIMA; TUNICA MEDIA; VARIATION (GENETICS);

EID: 34247273705     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000258869.48076.14     Document Type: Letter

References (7)

1. Davey Smith G, Timpson N, Lawlor DA. C-reactive protein and cardiovascular disease risk: still an unknown quantity? Ann Intern Med. 2006;145:70-72.
2. Juonala M, Viikari JS, Ronnemaa T, Taittonen L, Marniemi J, Raitakari OT. Childhood C-reactive protein in predicting CRP and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. Arterioscler Thromb Vasc Biol. 2006;26:1883-1888.
3. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol. 2000;29:722-729.
4. Davey Smith G, Lawlor DA, Harbord R, Timpson N, Rumley A, Lowe GD, Day IN, Ebrahim S. Association of C-reactive protein with blood pressure and hypertension: life course confounding and mendelian randomization tests of causality. Arterioscler Thromb Vasc Biol. 2005;25:1051-1056.
5. Timpson NJ, Lawlor DA, Harbord RM, Gaunt TR, Day IN, Palmer LJ, Hattersley AT, Ebrahim S, Lowe GD, Rumley A, Davey Smith G. C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet. 2005;366:1954-1959.
6. Casas JP, Shah T, Cooper J, Hawe E, McMahon AD, Gaffney D, Packard CJ, O'Reilly DS, Juhan-Vague I, Yudkin JS, Tremoli E, Margaglione M, Di Minno G, Hamsten A, Kooistra T, Stephens JW, Hurel SJ, Livingstone S, Colhoun HM, Miller GJ, Bautista LE, Meade T, Sattar N, Humphries SE, Hingorani AD. Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int J Epidemiol. 2006;35:922-931.
7. Lange LA, Carlson CS, Hindorff LA, Lange EM, Walston J, Durda JP, Cushman M, Bis JC, Zeng D, Lin D, Kuller LH, Nickerson DA, Psaty BM, Tracy RP. Reiner AP. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. J Am Med Assoc. 2006;296:2703-2711.